1416469-49-2

Upstream product

• 1416469-46-9 9-(3,4-dimethoxyphenyl)-7-(piperidin-4-yl)-7,8-diazaspiro[4.5]dec-8-en-6-one hydrochloride 
• 117142-26-4 (S)-2-tert-butoxycarbonylamino-3-pyridin-3-yl-propionic acid 
• 1416470-07-9 1-[2-(3,4-dimethoxyphenyl)-2-oxoethyl]cyclopentane carboxylic acid 
• 5623-90-5 2-oxaspiro[4.4]nonane-1,3-dione 
• 91-16-7 1,2-dimethoxybenzene 

Downstream Products

• 1416468-26-2 4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-N-[(2S)-1-{4-[9-(3,4-dimethoxyphenyl)-6-oxo-7,8-diazaspiro[4.5]dec-8-en-7-yl]piperidin-1-yl}-1-oxo-3-(pyridin-3-yl)propan-2-yl]-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide 
• 1416470-05-7 7-{1-[(2S)-2-amino-3-(pyridin-3-yl)propanoyl]piperidin-4-yl}-9-(3,4-dimethoxyphenyl)-7,8-diazaspiro[4.5]dec-8-en-6-one 

Relevant academic research and scientific papers

NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVES

The compounds of formula (1) in which R1, R7, R8, R9, R10, R17, R18, R19, R20 and m have the meanings as given in the description, are novel effective inhibitors of type 4 and type 5 phosphodiesterase.

NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVES

The compounds of formula (1), in which R1, R7, R8, R9, R10, R17, R18, R19, R20 and m have the meanings as given in the description, are novel effective inhibitors of type 4 and 5 phosphodiesterase.